![](/-/media/Images/News/2022/September-2022/0906RRCoronavirusMyocarditisBooster_SC.jpg?h=600&w=800&hash=419332E483EA5DCB2C75FE775462406C)
Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men
Sep 6, 2022
Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows.